Keenova

Keenova is a specialized therapeutics company established in 2025, operating within the global pharmaceutical and healthcare sectors. Headquartered in Dublin, Ireland, the firm focuses on developing targeted, science-based medical treatments designed to address critical gaps in patient care. By collaborating directly with healthcare providers and payors, Keenova ensures that patients receive essential therapies efficiently. The company’s strategic mission centers on bridging the divide between complex pharmaceutical innovation and practical clinical application, positioning itself as a key player in the evolving specialty medicine landscape.

The organization maintains a robust operational footprint with 1,000-5,000 employees dedicated to advancing its therapeutic pipeline. Keenova currently manages one primary facility located at the College Business & Technology Park in Blanchardstown, Dublin. This central hub serves as the core for its research, development, and administrative functions. The company’s product portfolio includes specialized therapeutic solutions and programmable logic controller systems, reflecting a diverse approach to healthcare technology. With a focus on high-impact medical outcomes, the firm leverages its internal expertise to streamline the delivery of specialty treatments across its target markets.

Keenova continues to scale its operations, reporting annual revenue of $540.1M. As a relatively new entity in the pharmaceutical space, the company prioritizes sustainable growth and strategic partnerships to enhance its market presence. Meet Keenova's team to learn more about the leadership driving these initiatives and the organizational structure supporting their long-term objectives. By maintaining a high-efficiency operational model, Keenova aims to set new standards in patient access and therapeutic efficacy.